Print
Email
Print Edition StoriesTuesday, December 22, 2009
Acceleron Pharma adds new VP roles
By Mass High Tech staff
MHT's Julie Donnelly: Pharmaceuticals find drug development partners in colleges
MHT's Julie Donnelly: Life science startups finding investments
MHT's Galen Moore: Hiring trends and opportunities
Following a regulatory filing for almost $11 million in equity financing, Cambridge biotech firm Acceleron Pharma Inc. has announced the addition of new hires in two newly created positions. Melissa Morandi has joined Acceleron as vice president of quality, while Kenneth Attie has taken the new role of vice president of medical research.
Morandi previously held the same vice president of quality role at Anesiva Inc. She held other quality-related leadership positions at Biogen Idec Inc., Genentech and Amgen. Morandi holds a master’s degree in immunology from California State University - Northbridge.
Attie formerly held the role of vice president of clinical development and medical affairs at Altus Pharmaceuticals. Prior to that position, he served as chief medical officer at Insmed, in charge of FDA approval and commercialization of one of the company’s products. He also held an assistant clinical professor of pediatrics role at the University of California San Francisco Medical Center. He graduated with a medical degree from New York University and is board-certified in pediatrics and pediatric endocrinology.
Acceleron develops preclinical protein treatments to combat bone loss, grow blood vessels and block fat growth.
The company was co-founded in 2004 by former Mass High Tech All-Star Cristoph Westphal, head of GlaxoSmithKline PLC’s Centre of Excellence for External Drug Discovery. It is backed by Advanced Technology Ventures, Bessemer Ventures, Flagship Ventures, MPM BioEquities, OrbiMed Advisors, Polaris Venture Partners, QVT Financial, Sutter Hill Ventures and Venrock.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
